This finding is contradictory with the results of the research groups of Shmuely et al (2001) and Hartwich et al, who reported that CagA+ seropositivity is associated with increased risk for both gastric and colonic cancer [35, 37]. This evidence concerns the gene S100A8 and colonic neoplasm.